Glomerular disease: Difference between revisions

Jump to navigation Jump to search
Line 216: Line 216:
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Sub-entity
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Sub-entity
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Causes and associations
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Causes and associations
! colspan="7" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History and Symtoms
! colspan="6" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |History and Symtoms
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
! colspan="3" |Pathology
! colspan="3" |Pathology
Line 233: Line 233:
|-
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History
! align="center" style="background:#4479BA; color: #FFFFFF;" + |History
!Systemic syptoms
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pitting edema
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pitting edema
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemeturia (pre-dominantly microscopic)
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemeturia (pre-dominantly microscopic)
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hypertension
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hypertension
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Oliguria
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Oliguria
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Peri-orbital edema
|-
|-
| rowspan="10" align="center" style="background:#4479BA; color: #FFFFFF;" + |Acute Nephritic Syndromes
| rowspan="11" align="center" style="background:#4479BA; color: #FFFFFF;" + |Acute Nephritic Syndromes
! colspan="2" |[[Poststreptococcal glomerulonephritis|Poststreptococcal Glomerulonephritis]]
! colspan="2" |[[Poststreptococcal glomerulonephritis|Poststreptococcal Glomerulonephritis]]
|Post infectios: group A beta-hemolytic streptococcus
|Post infectios: group A beta-hemolytic streptococcus
|History of prior skin or throat step infection
|History of prior skin or throat step infection
|<nowiki>+/-</nowiki>
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
Line 271: Line 269:
|Systemic immune reaction to bacterial endocarditis
|Systemic immune reaction to bacterial endocarditis
|History of infective endocarditis
|History of infective endocarditis
|<nowiki>+/-</nowiki>
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
Line 291: Line 288:
! colspan="2" |[[Lupus nephritis|Lupus Nephritis]]
! colspan="2" |[[Lupus nephritis|Lupus Nephritis]]
|SLE risk factors
|SLE risk factors
|History of SLE features
|
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
Line 307: Line 303:
|
|
|
|
|
|Differs based on the disease classification
|
|Differs based on the disease classification
|
|Differs based on the disease classification
|
|Disease presentation is different based on lupus nephritis classifications
|-
|-
! colspan="2" |[[Goodpasture syndrome|Antiglomerular Basement Membrane Disease]]
! colspan="2" |[[Goodpasture syndrome|Antiglomerular Basement Membrane Disease]]
Line 316: Line 312:
* Young adults
* Young adults
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
| -
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 344: Line 339:
* History of [[mucosal]] [[infections]] (e.g. [[gastroenteritis]]) and [[upper respiratory tract infection]]
* History of [[mucosal]] [[infections]] (e.g. [[gastroenteritis]]) and [[upper respiratory tract infection]]
* 2-3 days after [[infection]] (synpharyngitic)
* 2-3 days after [[infection]] (synpharyngitic)
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+/-</nowiki>
| -
| -
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
Line 364: Line 358:
|
|
|-
|-
! rowspan="3" |[[Vasculitis|ANCA Small-Vessel Vasculitis]]
! rowspan="4" |[[Vasculitis|ANCA Small-Vessel Vasculitis]]
! colspan="1" |[[Granulomatosis with polyangiitis|Granulomatosis with Polyangiitis (Wegener's)]]
! colspan="1" |[[Granulomatosis with polyangiitis|Granulomatosis with Polyangiitis (Wegener's)]]
|
|
|
|
| rowspan="2" |Constitutional symptoms, dysnea, purpura, arthralgias, and neurologic dysfunction
|
|
|
|
|
|
|
|ANCA
|
|
|
|
|
|
|
|-
! colspan="1" |[[Microscopic polyangiitis|Microscopic Polyangiitis]]
|
|
|
|
Line 386: Line 398:
|
|
|-
|-
! colspan="1" |[[Microscopic polyangiitis|Microscopic Polyangiitis]]
! colspan="1" |[[Eosinophilic granulomatosis with polyangiitis|Churg-Strauss Syndrome]]
|
|
|
|
|
Line 407: Line 418:
|
|
|-
|-
! colspan="1" |[[Eosinophilic granulomatosis with polyangiitis|Churg-Strauss Syndrome]]
|renal-limited vasculitis (RLV)
|
|
|
|
|
Line 438: Line 448:
* [[Periorbital edema]]
* [[Periorbital edema]]
* [[Hypertension]]
* [[Hypertension]]
|
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 459: Line 468:
|-
|-
! colspan="2" |Mesangioproliferative Glomerulonephritis
! colspan="2" |Mesangioproliferative Glomerulonephritis
|
|
|
|
|
Line 490: Line 498:
* [[Hodgkin's lymphoma|Hodgkin lymphoma]]
* [[Hodgkin's lymphoma|Hodgkin lymphoma]]
* [[Thrombosis]] (due to [[Urinary system|urinary]] loss of [[Antithrombin III|antithrombin-III]])
* [[Thrombosis]] (due to [[Urinary system|urinary]] loss of [[Antithrombin III|antithrombin-III]])
|
| +
| +
| -
| -
| -
| -
| -
| +/-
| +/-
| -
| +
| +
| +
| +
Line 521: Line 528:
|
|
* Adults
* Adults
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
Line 548: Line 554:
* [[Systemic lupus erythematosus]]
* [[Systemic lupus erythematosus]]
* Drugs ([[NSAIDS]], pencilamine, [[gold]], [[captopril]])
* Drugs ([[NSAIDS]], pencilamine, [[gold]], [[captopril]])
|
|
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
| +
| +
| +
| +
Line 570: Line 575:
|-
|-
! colspan="2" |[[Diabetic nephropathy|Diabetic Nephropathy]]
! colspan="2" |[[Diabetic nephropathy|Diabetic Nephropathy]]
|
|
|
|
|
Line 592: Line 596:
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + | Glomerular Deposition Diseases 
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + | Glomerular Deposition Diseases 
! colspan="2" |[[Light chain nephropathy|Light Chain Deposition Disease]]
! colspan="2" |[[Light chain nephropathy|Light Chain Deposition Disease]]
|
|
|
|
|
Line 613: Line 616:
|-
|-
! colspan="2" |[[Amyloidosis|Renal Amyloidosis]]
! colspan="2" |[[Amyloidosis|Renal Amyloidosis]]
|
|
|
|
|
Line 634: Line 636:
|-
|-
! colspan="2" |Fibrillary-Immunotactoid Glomerulopathy
! colspan="2" |Fibrillary-Immunotactoid Glomerulopathy
|
|
|
|
|
Line 655: Line 656:
|-
|-
! colspan="2" |[[Fabry's disease|Fabry's Disease]]
! colspan="2" |[[Fabry's disease|Fabry's Disease]]
|
|
|
|
|
Line 677: Line 677:
! rowspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Pulmonary-Renal Syndromes: 
! rowspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" + |Pulmonary-Renal Syndromes: 
! colspan="2" |[[Goodpasture syndrome|Goodpasture's syndrome]]
! colspan="2" |[[Goodpasture syndrome|Goodpasture's syndrome]]
|
|
|
|
|
Line 701: Line 700:
* [[Necrotizing]] [[vasculitis]] (no [[granuloma]])
* [[Necrotizing]] [[vasculitis]] (no [[granuloma]])
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
| +
| +
Line 727: Line 725:
* [[Peripheral neuropathy]]
* [[Peripheral neuropathy]]
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 748: Line 745:
|-
|-
! colspan="2" |[[Henoch-Schönlein purpura]] 
! colspan="2" |[[Henoch-Schönlein purpura]] 
|
|
|
|
|
Line 769: Line 765:
|-
|-
! colspan="2" |[[Cryoglobulinemia]]
! colspan="2" |[[Cryoglobulinemia]]
|
|
|
|
|
Line 791: Line 786:
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Basement Membrane Syndrome
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Basement Membrane Syndrome
! colspan="2" |[[Anti-glomerular basement membrane antibody|Anti-GBM Disease]]
! colspan="2" |[[Anti-glomerular basement membrane antibody|Anti-GBM Disease]]
|
|
|
|
|
Line 812: Line 806:
|-
|-
! colspan="2" |[[Alport syndrome|Alport's Syndrome]]
! colspan="2" |[[Alport syndrome|Alport's Syndrome]]
|
|
|
|
|
Line 833: Line 826:
|-
|-
! colspan="2" |[[Thin basement membrane disease|Thin Basement Membrane Disease]]
! colspan="2" |[[Thin basement membrane disease|Thin Basement Membrane Disease]]
|
|
|
|
|
Line 854: Line 846:
|-
|-
! colspan="2" |[[Nail-patella syndrome|Nail-Patella Syndrome]]
! colspan="2" |[[Nail-patella syndrome|Nail-Patella Syndrome]]
|
|
|
|
|
Line 876: Line 867:
! rowspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + | Glomerular-Vascular Syndromes 
! rowspan="6" align="center" style="background:#4479BA; color: #FFFFFF;" + | Glomerular-Vascular Syndromes 
! colspan="2" |Atherosclerotic Nephropathy
! colspan="2" |Atherosclerotic Nephropathy
|
|
|
|
|
Line 897: Line 887:
|-
|-
! colspan="2" |[[Hypertensive nephropathy|Hypertensive Nephrosclerosis]]
! colspan="2" |[[Hypertensive nephropathy|Hypertensive Nephrosclerosis]]
|
|
|
|
|
Line 918: Line 907:
|-
|-
! colspan="2" |[[Cholesterol emboli syndrome|Cholesterol Emboli]]
! colspan="2" |[[Cholesterol emboli syndrome|Cholesterol Emboli]]
|
|
|
|
|
Line 939: Line 927:
|-
|-
! colspan="2" |[[Sickle-cell disease|Sickle Cell Disease]]
! colspan="2" |[[Sickle-cell disease|Sickle Cell Disease]]
|
|
|
|
|
Line 960: Line 947:
|-
|-
! colspan="2" |[[Thrombotic microangiopathies|Thrombotic Microangiopathies]]
! colspan="2" |[[Thrombotic microangiopathies|Thrombotic Microangiopathies]]
|
|
|
|
|
Line 981: Line 967:
|-
|-
! colspan="2" |[[Antiphospholipid syndrome|Antiphospholipid Antibody Syndrome]] 
! colspan="2" |[[Antiphospholipid syndrome|Antiphospholipid Antibody Syndrome]] 
|
|
|
|
|
Line 1,008: Line 993:
* 2-3 weeks after [[infection]]
* 2-3 weeks after [[infection]]
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+</nowiki>
|
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
Line 1,029: Line 1,013:
|-
|-
! colspan="2" |[[Subacute bacterial endocarditis|Subacute Bacterial Endocarditis]]
! colspan="2" |[[Subacute bacterial endocarditis|Subacute Bacterial Endocarditis]]
|
|
|
|
|
Line 1,050: Line 1,033:
|-
|-
! colspan="2" |[[Human Immunodeficiency Virus (HIV)|Human Immunodeficiency Virus]]
! colspan="2" |[[Human Immunodeficiency Virus (HIV)|Human Immunodeficiency Virus]]
|
|
|
|
|
Line 1,071: Line 1,053:
|-
|-
! colspan="2" |[[Hepatitis|Hepatitis B and C]]
! colspan="2" |[[Hepatitis|Hepatitis B and C]]
|
|
|
|
|
Line 1,092: Line 1,073:
|-
|-
! colspan="2" |Other Viruses
! colspan="2" |Other Viruses
|
|
|
|
|
Line 1,113: Line 1,093:
|-
|-
! colspan="2" |[[Syphilis]]
! colspan="2" |[[Syphilis]]
|
|
|
|
|
Line 1,134: Line 1,113:
|-
|-
! colspan="2" |[[Leprosy]]
! colspan="2" |[[Leprosy]]
|
|
|
|
|
Line 1,155: Line 1,133:
|-
|-
! colspan="2" |[[Malaria]]
! colspan="2" |[[Malaria]]
|
|
|
|
|
Line 1,176: Line 1,153:
|-
|-
! colspan="2" |[[Schistosomiasis]]
! colspan="2" |[[Schistosomiasis]]
|
|
|
|
|
Line 1,197: Line 1,173:
|-
|-
! colspan="2" |Other [[Parasites]]
! colspan="2" |Other [[Parasites]]
|
|
|
|
|

Revision as of 02:34, 29 May 2018

This page contains general information about Glomerular disease. For more information on specific types, please visit the pages on nephritic syndrome, nephrotic syndrome, Fabry's disease, amyloidosis, pulmonary-renal syndromes (vasculitis), thin basement membrane disease, Alport's Syndrome, anti-GBM Disease, hypertensive nephrosclerosis, and subacute bacterial endocarditis.

Glomerular disease
Acute Glomerulonephritis: Micro H&E high mag; an excellent example of acute exudative glomerulonephritis.
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Glomerular disease Main page

Glomerular disease patient information

Overview

Classification

1- Poststreptococcal Glomerulonephritis
2- Renal disease due to Subacute Bacterial Endocarditis, or cardiac shunt
3- Lupus nephritis
4- Goodpasture syndrome
5- IgA nephropathy
6- Granulomatosis with Polyangiitis (Wegener's)
7- Microscopic Polyangiitis
8- Churg-Strauss Syndrome
9- Membranoproliferative Glomerulonephritis
10- Henoch-Schönlein purpura
11- Cryoglobulinemia
12- Minimal change disease
13- Focal segmental glomerulosclerosis
14- Membranous glomerulonephritis
15- Diabetic Nephropathy
16- Glomerular deposition disease
17- Alport's Syndrome
18- Thin Basement Membrane Disease
19- Nail-Patella Syndrome
20- Hypertensive nephrosclerosis
21- Cholesterol Emboli
22- Sickle Cell Disease
23- Thrombotic Microangiopathies
24- Antiphospholipid Antibody Syndrome

Pathophysiology

Differential Diagnosis

Diagnosis

Prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2], Syed Hassan A. Kazmi BSc, MD [3]

Overview

Glomerular disease is a condition that affects the glomerulus. It consists of different diseases with different clinical courses and treatment options. Glomerular disease can be isolated hematuria, isolated proteinuria; acute or chronic glomerulonephritis, and nephrotic or nephritic features of glomerulonephritis. The end stage of all of these diseases will be glomerulosclerosi swhich is characterized by fibrosis of the glomerulus, and end-stage renal disease.


Classification

Glomerular dieseases can be classified into several clinical and pathological syndromes as below:

Syndrome Disease
Acute nephritic syndromes
Nephrotic syndrome
Glomerular Deposition Diseases
Pulmonary-Renal Syndromes:
Basement Membrane Syndromes
Glomerular-Vascular Syndromes
Infectious Disease–Associated Syndromes

Also, glomerular diseases can be classified based on their clinical and urinary pattern in to below types:

Mild nephritc:

This category include mild nephritic sediment that is associated with less than half involvement of glomeruli.

Severe nephritic:

More severe clinical features such as edema, heavy proteinuria, hypertension, and/or renal failure may occur.

Nephrotic:

This syndrome is associated with heavy proteinuria and lipiduria.

Glomerular diseases also may classified by their presentation as below:

Glomerular hematuria:

1- Isolated hematuria

2- Glomerulonephritis (nephritic syndrome)

Proteinuria:

1-Isolated non-nephrotic proteinuria 

2- Nephrotic syndrome

Rapidly progressive glomerulonephritis

Glomerulonephritis

Glomerulonephritis which is inflammation of the glomeruli can be classified based on pathogenic type into three subtypes:

  • Anti-GBM disease: Linear deposit
    1. Goodpasture syndrome (renal and lung involvement)
    2. Renal involvement alone
    3. Lung involvement alone

Glomerulonephritis (nephritic syndrome) also may be classified based on disease course into acute or chronic nephritic syndrome; primary vs secondary causes; or systemic vs renal limited disease. For more information about nephritic syndrome classifications click here.

Pathophysiology

Microscopic Pathology

Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology


Glomerulonephritis Videos

Rapidly progressive glomerulonephritis

{{#ev:youtube|CqSyj4cVZPE}}


Chronic glomerulonephritis

{{#ev:youtube|eA1vYarRAWo}}

Images

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Images:


Differential Diagnosis

Glomerulonephritis may be proliferative or non-proliferative and may be associated with nephrotic or nephritic features. The various types of glomerulonephritides should be differentiated from each other based on associations, presence of pitting edema, hemeturia, hypertension, hemoptysis, oliguria, peri-orbital edema, hyperlipidemia, type of antibodies, light and electron microscopic features. The following table differentiates between various types of glomerulonephritides:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24]

Glomerular diseases Sub-entity Causes and associations History and Symtoms Laboratory Findings Pathology Comments
Hyperlipidemia and hypercholesterolemia Nephrotic features Nephritic features Antibodies ANCA Anti-glomerular basement membrane antibody (Anti-GBM antibody) Immune complex formation Light microscope Electron microscope Immunoflourescence pattern
History Systemic syptoms Pitting edema Hemeturia (pre-dominantly microscopic) Hypertension Oliguria
Acute Nephritic Syndromes Poststreptococcal Glomerulonephritis Post infectios: group A beta-hemolytic streptococcus History of prior skin or throat step infection +/- +/- +/- +/- +/- +/- +/-
  • Anti-DNA antibodies
  • Anti-C1q antibodies
  • Antineutrophil cytoplasmic antibodies (ANCA)
  • diffuse proliferative glomerulonephritis
  • prominent endocapillary proliferation and numerous neutrophils 
  • small subepithelial hump-shaped deposits
Pathologic involvement correlates with the clinical findings
Subacute Bacterial Endocarditis Systemic immune reaction to bacterial endocarditis History of infective endocarditis +/- +/- +/- +/- +/- +/- +/-
Lupus Nephritis SLE risk factors History of SLE features +/- +/- +/- +/- +/- +/- +/- anti-C1q antibodies

anti-dsDNA

Differs based on the disease classification Differs based on the disease classification Differs based on the disease classification Disease presentation is different based on lupus nephritis classifications
Antiglomerular Basement Membrane Disease
  • Young adults
+/- + + + + - + - + + + (Linear)
IgA Nephropathy +/- + + + - - + - - +
  • Crescent formation
-
ANCA Small-Vessel Vasculitis Granulomatosis with Polyangiitis (Wegener's) Constitutional symptoms, dysnea, purpura, arthralgias, and neurologic dysfunction ANCA
Microscopic Polyangiitis
Churg-Strauss Syndrome
renal-limited vasculitis (RLV)
Membranoproliferative Glomerulonephritis +/- + + + - + - - - + + (Granular)
Mesangioproliferative Glomerulonephritis
Nephrotic Syndrome Minimal Change Disease + - - +/- + + - - - -
  • Normal
-
Focal Segmental Glomerulosclerosis
  • Adults
+ - - +/- + + - - - - -
Membranous Glomerulonephritis + - - +/- + + - - - + -
Diabetic Nephropathy
 Glomerular Deposition Diseases  Light Chain Deposition Disease
Renal Amyloidosis
Fibrillary-Immunotactoid Glomerulopathy
Fabry's Disease
Pulmonary-Renal Syndromes:  Goodpasture's syndrome
Microscopic polyangiitis +/- + + + + - +

+ (P-ANCA)

- - - (pauci-immune) -
Churg-Strauss vasculitis +/- + + + + - +

+ (C-ANCA)

- - - (pauci-immune) -
Henoch-Schönlein purpura 
Cryoglobulinemia
Basement Membrane Syndrome Anti-GBM Disease
Alport's Syndrome
Thin Basement Membrane Disease
Nail-Patella Syndrome
 Glomerular-Vascular Syndromes  Atherosclerotic Nephropathy
Hypertensive Nephrosclerosis
Cholesterol Emboli
Sickle Cell Disease
Thrombotic Microangiopathies
Antiphospholipid Antibody Syndrome 
 Infectious Disease–Associated Syndromes  Post-Streptococcal Glomerulonephritis +/- + + + + - + - - + + (Granular)
Subacute Bacterial Endocarditis
Human Immunodeficiency Virus
Hepatitis B and C
Other Viruses
Syphilis
Leprosy
Malaria
Schistosomiasis
Other Parasites

References

  1. Saha TC, Singh H (November 2006). "Minimal change disease: a review". South. Med. J. 99 (11): 1264–70. doi:10.1097/01.smj.0000243183.87381.c2. PMID 17195422.
  2. Saleem MA, Kobayashi Y (2016). "Cell biology and genetics of minimal change disease". F1000Res. 5. doi:10.12688/f1000research.7300.1. PMC 4821284. PMID 27092244.
  3. Keskar V, Jamale TE, Kulkarni MJ, Kiggal Jagadish P, Fernandes G, Hase N (October 2013). "Minimal-change disease in adolescents and adults: epidemiology and therapeutic response". Clin Kidney J. 6 (5): 469–72. doi:10.1093/ckj/sft063. PMC 4438390. PMID 26064510.
  4. Chugh SS, Clement LC, Macé C (February 2012). "New insights into human minimal change disease: lessons from animal models". Am. J. Kidney Dis. 59 (2): 284–92. doi:10.1053/j.ajkd.2011.07.024. PMC 3253318. PMID 21974967.
  5. Rosenberg AZ, Kopp JB (March 2017). "Focal Segmental Glomerulosclerosis". Clin J Am Soc Nephrol. 12 (3): 502–517. doi:10.2215/CJN.05960616. PMC 5338705. PMID 28242845.
  6. Jefferson JA, Shankland SJ (September 2014). "The pathogenesis of focal segmental glomerulosclerosis". Adv Chronic Kidney Dis. 21 (5): 408–16. doi:10.1053/j.ackd.2014.05.009. PMC 4149756. PMID 25168829.
  7. Gephardt GN, Tubbs RR, Popowniak KL, McMahon JT (October 1986). "Focal and segmental glomerulosclerosis. Immunohistologic study of 20 renal biopsy specimens". Arch. Pathol. Lab. Med. 110 (10): 902–5. PMID 2429634.
  8. Lai WL, Yeh TH, Chen PM, Chan CK, Chiang WC, Chen YM, Wu KD, Tsai TJ (February 2015). "Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment". J. Formos. Med. Assoc. 114 (2): 102–11. doi:10.1016/j.jfma.2014.11.002. PMID 25558821.
  9. Wasserstein AG (April 1997). "Membranous glomerulonephritis". J. Am. Soc. Nephrol. 8 (4): 664–74. PMID 10495797.
  10. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA (October 2011). "The pathophysiology of IgA nephropathy". J. Am. Soc. Nephrol. 22 (10): 1795–803. doi:10.1681/ASN.2011050464. PMC 3892742. PMID 21949093.
  11. Wyatt RJ, Julian BA (June 2013). "IgA nephropathy". N. Engl. J. Med. 368 (25): 2402–14. doi:10.1056/NEJMra1206793. PMID 23782179.
  12. He S, Wu Z (November 2011). "Gene-based Higher Criticism methods for large-scale exonic single-nucleotide polymorphism data". BMC Proc. 5 Suppl 9: S65. doi:10.1186/1753-6561-5-S9-S65. PMC 3287904. PMID 22373436.
  13. Higgins RM, Goldsmith DJ, Connolly J, Scoble JE, Hendry BM, Ackrill P, Venning MC (January 1996). "Vasculitis and rapidly progressive glomerulonephritis in the elderly". Postgrad Med J. 72 (843): 41–4. PMC 2398323. PMID 8746284.
  14. Jennette JC (March 2003). "Rapidly progressive crescentic glomerulonephritis". Kidney Int. 63 (3): 1164–77. doi:10.1046/j.1523-1755.2003.00843.x. PMID 12631105.
  15. Bolton WK (November 1996). "Goodpasture's syndrome". Kidney Int. 50 (5): 1753–66. PMID 8914046.
  16. Mathew TH, Hobbs JB, Kalowski S, Sutherland PW, Kincaid-Smith P (February 1975). "Goodpasture's syndrome: normal renal diagnostic findings". Ann. Intern. Med. 82 (2): 215–8. PMID 1090223.
  17. Renaudineau Y, Le Meur Y (October 2008). "Renal involvement in Wegener's granulomatosis". Clin Rev Allergy Immunol. 35 (1–2): 22–9. doi:10.1007/s12016-007-8066-6. PMID 18172777.
  18. Weiss MA, Crissman JD (October 1984). "Renal biopsy findings in Wegener's granulomatosis: segmental necrotizing glomerulonephritis with glomerular thrombosis". Hum. Pathol. 15 (10): 943–56. PMID 6384024.
  19. Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C (May 2006). "Renal involvement in Churg-Strauss syndrome". Am. J. Kidney Dis. 47 (5): 770–9. doi:10.1053/j.ajkd.2006.01.026. PMID 16632015.
  20. Cartin-Ceba R, Keogh KA, Specks U, Sethi S, Fervenza FC (September 2011). "Rituximab for the treatment of Churg-Strauss syndrome with renal involvement". Nephrol. Dial. Transplant. 26 (9): 2865–71. doi:10.1093/ndt/gfq852. PMC 3218640. PMID 21325353.
  21. Chung SA, Seo P (August 2010). "Microscopic polyangiitis". Rheum. Dis. Clin. North Am. 36 (3): 545–58. doi:10.1016/j.rdc.2010.04.003. PMC 2917831. PMID 20688249.
  22. Pagnoux C (March 2008). "[Wegener's granulomatosis and microscopic polyangiitis]". Rev Prat (in French). 58 (5): 522–32. PMID 18524109.
  23. Alchi B, Jayne D (August 2010). "Membranoproliferative glomerulonephritis". Pediatr. Nephrol. 25 (8): 1409–18. doi:10.1007/s00467-009-1322-7. PMC 2887509. PMID 19908070.
  24. Davis AE, Schneeberger EE, Grupe WE, McCluskey RT (May 1978). "Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children". Clin. Nephrol. 9 (5): 184–93. PMID 657595.

Related Chapters

Template:Nephrology

Template:WH Template:WS